From November 5th-10th the Guerriero lab attended the 39th SITC annual meeting in Houston. It was a week full of great presentations and conversations with colleagues. We hope to see you next year at the 40th annual meeting in Maryland.
On October 4th, we celebrated the 4th anniversary of the Guerriero Lab. The past 4 years have been filled with great science, collaborations, and people. Can't wait to see what we can accomplish next.
It was a privilege to present our research at the Association for Cancer Immunotherapy (CIMT) conference this year in Mainz Germany. It was a fantastic three days of great talks and discussions.
Congratulations to Adam Nelson on winning a 2023 Canadian Health Institute of Research Fellowship for his project targeting macrophages in breast cancer! Congratulations and well deserved!
Congratulations to Dr. Jennifer Guerriero on her new appointment as the Department of Surgery Faculty Convener! Through this role she will serve as a liaison to foster communication between department leadership and laboratory based researchers, as well as to engage…
Guerriero lab was in full force at AACR 2024 in San Diego. Great conference full of great talks. We were so glad to meet up with collaborators and participate in Runners for Research 5K run. We hope to see you…
The Guerriero Lab joined thousands of other researchers in San Diego for SITC 2023. It was full of great talks and discussions. Congratulations to Carlos and Adam for winning the Presidential Travel Award and Young Investigator Award, respectively. We hope…
Today is the Guerriero Lab's 3rd year anniversary! Thank you to all of our members and collaborators over the last three years. Here is to many more successful years of breast cancer and macrophage research!
Congratulations to Dr. Adam Nelson on winning a 2023 John A. Mannick Research Award for his work in targeting macrophages during PARP inhibitor therapy. Adam presented his work at the 29th Annual Department of Surgery John A. Mannick Research Award…
Fantastic poster presentations by Kenichi and Dan at the DanaFarber Molecular and Cellular Oncology Retreat. They both presented new stories and data on elucidating mechanisms of therapy resistance in breast cancer.